DOC
Healthpeak Properties, Inc.
Healthpeak Properties, Inc. insider trading
Every time one of DOC's executives or directors buys or sells the stock, the filing appears here the moment it reaches the SEC — with grants and option exercises set apart from the trades that cost the insider their own money.
SEC Form 4 data, Q3 2024 to Q2 2026
DOC insider trading by quarter
Between Jul 01, 2024 and Jun 30, 2026, 8 insiders traded DOC on the open market: 14 purchases worth $1.1M and 1 sale worth $213.7K. In the last four quarters alone: 4 purchases ($149.8K) and 1 sale ($213.7K), by 3 insiders.
| Quarter | Bought | Sold | Insiders |
|---|---|---|---|
| Q2 2026 | — | −$213.7K1 sale | |
| Q1 2026 | — | — | |
| Q4 2025 | — | — | |
| Q3 2025 | +$149.8K4 buys | — | |
| Q2 2025 | +$966.3K10 buys | — | |
| Q1 2025 | — | — | |
| Q4 2024 | — | — | |
| Q3 2024 | — | — |
- Largest purchase
- +$200.4K of DOC by Brinker Scott M (President and CEO · Director) on Apr 28, 2025.
- Largest sale
- −$213.7K of DOC by Bohn Scott R (CDO and Head of Lab) on May 12, 2026.
Open-market transactions through Jun 30, 2026most recent first
Bohn Scott R
CDO and Head of Lab
−$213.7K
May 12, 2026
10,989 sh · $19.45
Thomas John T
Director
+$24.7K
Aug 06, 2025
1,450 sh · $17.06
Brinker Scott M
President and CEO · Director
+$25.1K
Aug 04, 2025
1,490 sh · $16.83
Brinker Scott M
President and CEO · Director
+$50K
Jul 31, 2025
2,930 sh · $17.06
Brinker Scott M
President and CEO · Director
+$50K
Jul 28, 2025
2,873 sh · $17.40
Thompson Tommy G
Director
+$99.8K
May 28, 2025
5,777 sh · $17.27
Thompson Tommy G
Director
+$99K
May 09, 2025
5,700 sh · $17.36
Brinker Scott M
President and CEO · Director
+$47.8K
May 09, 2025
2,750 sh · $17.39
Lias-Booker Ava
Director
+$89.2K
Apr 29, 2025
5,000 sh · $17.83
Brinker Scott M
President and CEO · Director
+$200.4K
Apr 28, 2025
11,337 sh · $17.68
Sandstrom Katherine M
Director
+$199.2K
Apr 28, 2025
11,288 sh · $17.65
Lewis Sara Grootwassink
Director
+$106K
Apr 28, 2025
6,000 sh · $17.66
Thomas John T
Director
+$74.9K
Apr 28, 2025
4,200 sh · $17.84
Shelley-Kessler Pamela
Director
+$25K
Apr 28, 2025
1,420 sh · $17.61
Shelley-Kessler Pamela
Director
+$25K
Apr 28, 2025
1,418 sh · $17.63
| Date | Insider | Shares | Price | Value |
|---|---|---|---|---|
| May 12, 2026 | Bohn Scott RCDO and Head of Lab | 10,989 | $19.45 | −$213.7K |
| Aug 06, 2025 | Thomas John TDirector | 1,450 | $17.06 | +$24.7K |
| Aug 04, 2025 | Brinker Scott MPresident and CEO · Director | 1,490 | $16.83 | +$25.1K |
| Jul 31, 2025 | Brinker Scott MPresident and CEO · Director | 2,930 | $17.06 | +$50K |
| Jul 28, 2025 | Brinker Scott MPresident and CEO · Director | 2,873 | $17.40 | +$50K |
| May 28, 2025 | Thompson Tommy GDirector | 5,777 | $17.27 | +$99.8K |
| May 09, 2025 | Thompson Tommy GDirector | 5,700 | $17.36 | +$99K |
| May 09, 2025 | Brinker Scott MPresident and CEO · Director | 2,750 | $17.39 | +$47.8K |
| Apr 29, 2025 | Lias-Booker AvaDirector | 5,000 | $17.83 | +$89.2K |
| Apr 28, 2025 | Brinker Scott MPresident and CEO · Director | 11,337 | $17.68 | +$200.4K |
| Apr 28, 2025 | Sandstrom Katherine MDirector | 11,288 | $17.65 | +$199.2K |
| Apr 28, 2025 | Lewis Sara GrootwassinkDirector | 6,000 | $17.66 | +$106K |
| Apr 28, 2025 | Thomas John TDirector | 4,200 | $17.84 | +$74.9K |
| Apr 28, 2025 | Shelley-Kessler PamelaDirector | 1,420 | $17.61 | +$25K |
| Apr 28, 2025 | Shelley-Kessler PamelaDirector | 1,418 | $17.63 | +$25K |
From SEC's quarterly Form 3, 4 and 5 data sets: code P purchases and code S sales of common stock, by the date the trade happened. Where a fund and the people who control it each report the same block, it is counted once. Trades made in the last days of Q2 2026 but filed after it closed arrive with SEC's next quarterly release.
After insiders bought DOC
What the stock actually did in the 90 days following each open-market purchase
Don't check DOC — let it ping you
Get told the moment an insider moves on DOC
Pro watches Healthpeak Properties, Inc. for you and sends a Telegram ping within moments of a Form 4 clearing EDGAR — a C-suite open-market buy, a cluster, a 10b5-1 regime break — long before it reaches the press. Add DOC to a watchlist, see each mover's benchmark-measured track record and which legendary funds hold it, and read the full filing history instead of the last 72 hours.
The live dashboard is free to open. Alerts, watchlists, full filing history and each mover's benchmark-measured track record are Pro. Monitoring, not advice.
How to read DOC insider activity
- Open-market purchase (code P)
- An insider spending their own money at market price. This is the only buy code that reliably carries signal — it is a decision, not compensation.
- Grants and option exercises (codes A, M)
- Scheduled compensation. Most "insider buying" headlines are really this, which is why InsiderPulse weights it at a fraction of a real purchase.
- Cluster buy
- Two or more different insiders buying on the open market in the same window. One executive buying can mean anything; three is much harder to explain away.
Other Real Estate tickers
Questions
- How much DOC stock have insiders bought and sold in the last two years?
- Between Jul 01, 2024 and Jun 30, 2026, 8 Healthpeak Properties, Inc. insiders made 14 open-market purchases worth $1.1M and 1 sale worth $213.7K. In the four quarters to Jun 30, 2026: 4 purchases ($149.8K) and 1 sale ($213.7K). The largest purchase was Brinker Scott M buying $200.4K on Apr 28, 2025. The largest sale was Bohn Scott R selling $213.7K on May 12, 2026.
- Where does DOC insider trading data come from?
- From the Form 4 filings Healthpeak Properties, Inc.'s officers, directors and 10% owners must send the SEC within two business days of a trade. Each row on this page links to its original filing on SEC EDGAR. Share grants and option exercises are kept apart from open-market purchases and sales, because only the latter cost the insider their own money.
Get the free Insider Brief
Each weekday evening: the day's biggest open-market insider buys, cluster formations and 10b5-1 plan breaks — in plain English, with grants and routine vesting stripped out. Honest about what the data can and cannot say.